Professor Wu Xiuyi, Wu Nan, and Li Danqing shared the secrets of lung cancer's long -term survival secrets

Author:Chinese Anti -Cancer Associati Time:2022.08.01

In the past 10 years, the mortality rate of lung cancer has gradually declined [1].

According to the observations of lung Xiaofan, in recent years, more and more patients with long -lived lung cancer have more and more long -lived lung cancer patients with 5 years, 10 years, or longer. Why can these lung cancer patients defeat lung cancer on the road of anti -cancer and become anti -cancer heroes for friends to learn? The speculation of the lung Xiaofan is as follows:

First of all, with the widespread development of low -dose spiral CT screening in recent years, more and more lung cancer has been discovered in the early stage. In the past, the situation of "once diagnosis is advanced lung cancer", and it is gradually decreasing. It is early lung cancer, the higher the survival rate. For example, the survival rate of patients with stage ⅠA may reach 92%[2].

At the same time, the treatment of lung cancer has also made breakthroughs. Although the treatment of surgical surgery is still an important treatment for the cure of early lung cancer, lung cancer surgery is also increasingly fine today. This not only reduces the trauma and pain caused by patients with lung cancer, but also shorten the postoperative hospitalization time; various types Postoperative auxiliary treatment methods have also been continuously obtained by clinical verification. This not only reduces the risk of postoperative recurrence and metastasis, but also brings the hope of long survival.

In addition, while the anti -cancer heroes are pursuing "living longer", they also hope to "live better" on this long -term anti -cancer road. Therefore, many anti -cancer heroes not only won the battle in the battle of anti -cancer, but also fought a beautiful battle.

So, how does anti -cancer heroes achieve the common victory of "live longer" and "better live"? There is a lot of knowledge hidden here.

To this end, on the 6th anniversary of the "Pulmonary Power", the lung Xiaofan opened a popular science live broadcast entitled "Ben 6, and the anti -cancer road they walked together."

This live broadcast is the first event of "Pulmonary Power" this year. As the first live broadcast, Lung Xiaofan was very honored to invite three heavyweight Beijing lung cancer experts: Professor Zhixiuyi from Xuanwu Hospital of Capital Medical University, Professor Wu Nan from Peking University Cancer Hospital, and Beijing Union Hospital Professor Li Shanqing.

And in this live broadcast, Professor Zhi Xiuyi will talk to a patient with long -survive lung cancer to discuss the important secrets of achieving the survival of lung cancer.

In addition, Professor Wu Nan and Professor Li Shanqing will also discuss the following questions for friends:

Which lung cancer patients can undergo surgery?

What are the precautions after surgery?

Do you need postoperative supplementary treatment after surgery?

Auxiliary chemotherapy, auxiliary immunotherapy, and auxiliary immunotherapy, how should patients with lung cancer choose?

In addition, what other methods can improve the survival rate and quality of life of lung cancer?

Native

I believe that there are still many questions to ask friends who want to ask these three experts. Then, the lung Xiaofan sincerely invites all friends to find friends and actively participate in the first live broadcast of this "Pulmonary Power". 6 No interest, more than just learning!

Live information

Live broadcast time

August 222, 17: 00-19: 00

Live appointment

Pay attention to the public account of the Chinese Anti -Cancer Association Popular Science Platform, and make an appointment for public welfare live broadcast on the day

Expert introduction

Professor Zhixiuyi

Chief expert

National Health Popularization expert

Minister of Popular Science Propaganda Department of China Anti -Cancer Association

Director of Lung Cancer Center, Beijing Chang Gung Hospital affiliated to Tsinghua University

Minister of Popular Science Propaganda Department of China Anti -Cancer Association

Chairman of China Cheung Cancer Alliance

Director of the China Cancer Foundation and Minister of Science and Technology

Vice President of China Control of Smoking Association and Chairman of the Pulmonary Cancer Prevention and Control Branch

Chairman of the China Pharmaceutical Education Association of Lung Cancer Medical Education Committee

Chairman of the Chinese Medical Promotional Promotional Cancer Prevention and Control Branch

Professor Wu Nan

Deputy Dean of Peking University Cancer Hospital, Deputy Director of Chest Cancer Center

PhD, chief physician, professor, doctoral supervisor

Experts from special allowances of the State Council

President of the Member Committee of the International Lung Cancer Research Association (IASLC)

Member of the Cancer Branch of the Chinese Medical Association

Member of the Chemical Cardiac Scholaring Branch of China Cheung Cardiovascular Surgery Branch

Standing Committee Member of the Chinese Physician Association Cancer Multi -Disciplinary Diagnosis and Treatment Commission, Member of the Chestning Surgery Branch

Deputy Chairman of the Cancer Chemical Treatment Professional Committee of China Medical Education Association

Standing Committee of the Senior Cancer Branch of Chinese Elderly and Elderly Medical Society

Deputy Chairman of the Beijing Medical Association Oncology Branch

Standing Committee Standing Committee of Chest Surgery Branch

Professor Li Shanqing

Secretary of the Party Branch and Director of Chemical Surgery of Beijing Union Hospital of Xiehe Hospital

Chief physician PhD instructor

Executive Director of the International Exchange Promotion Association of China Medical and Healthcare and Deputy Chairman of the Chestnack Branch

Deputy Chairman and Secretary -General of the China Medical Foundation's Chestning Professional Committee

Executive Member of the Chinese Medical Association's chest, cardiovascular vascular surgery

Standing Member of the Deep Surgery Branch of the Chinese Medical Association, a member of the Minimally Invasive Surgery Commission, and a member of the esophagus and management expert committee

Executive Member of the World Chinese Physician Association

Ministry of Science and Technology National Key R & D Plan "Smart Robot" key special scientist

Deputy Chairman of the Chinese Medical Association Beijing Breast Science Society

Executive Director of the Beijing Medical Association's Chemistry Branch

Deputy Leader of the Professional Team of the Beijing Medical Association's Cheung Cancer Professional Group

Member of the Professional Committee of Beijing Traditional Chinese and Western Medicine Society

Member of the Academy of Sciences of Greater China

What is "lung force"?

"Pulmonary Power" is a large -scale lung cancer disease science education lecture sponsored by the China Anti -Cancer Association's Oncology Prevention Science Science Commission and organized by the cooperation of Jianjia. Patients with lung cancer solve the problem of anti -cancer roads and avoid letting patients with lung cancer take detours on anti -cancer roads. The "Pulmonary Power" has been carried out for 5 consecutive years. In the past five years, the "lung force" has affected millions of patients and family members of lung cancer. This year is the sixth year of the "lung force". Run 6 for 6, science more than science! The Chinese Anti -Cancer Association Cancer Science Science Commission will continue to bring the general public for the popular science activities, improve people's awareness of anti -cancer, anti -cancer, and popularize the standardized diagnosis and treatment of cancer.

references

[1] https://www.sciencedirect.com/science/article/pii/s266700542000047

[2]Goldstraw P, Chansky K, Crowley J, et al. The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer. J Thorac Oncol. 2016 ; 11 (1): 39-51.

- END -

Sichuan July 22nd added 11 new local diagnosis cases, and 10 cases of non -symptomatic infection were added

From 0:00 on July 22 to 24, there were 11 new local diagnosis cases (in Chengdu) i...

A rumor also brought a faucet with eye -catching medicine, and Xingqi's eye medicine plummeted 16%, and the market value was not 2.4 billion.

Following the crash of Goor's shares, the eye medicine of the ophthalmology was al...